isopentenyl pyrophosphate has been researched along with Bone Cancer in 2 studies
isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MDA-MB-231, T47D and MCF-7 breast cancer cells were treated with BP (zoledronic acid, risedronate, ibandronate, alendronate) and the pyrophosphate channel inhibitors probenecid and novobiocin." | 7.80 | Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells. ( Auriola, S; Coimbra de Sousa, S; Ebert, R; Graser, S; Hofbauer, LC; Jakob, F; Määttä, J; Meissner-Weigl, J; Mentrup, B; Rachner, TD; Zeck, S, 2014) |
| "MDA-MB-231, T47D and MCF-7 breast cancer cells were treated with BP (zoledronic acid, risedronate, ibandronate, alendronate) and the pyrophosphate channel inhibitors probenecid and novobiocin." | 3.80 | Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells. ( Auriola, S; Coimbra de Sousa, S; Ebert, R; Graser, S; Hofbauer, LC; Jakob, F; Määttä, J; Meissner-Weigl, J; Mentrup, B; Rachner, TD; Zeck, S, 2014) |
| " However, bisphosphonates exhibit a high affinity for bone mineral, which reduces their bioavailability for tumor cells." | 1.42 | Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer. ( Clézardin, P; Gineyts, E; Melodelima, D; Ngo, J; Roux, JP; Tardoski, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, R | 1 |
| Meissner-Weigl, J | 1 |
| Zeck, S | 1 |
| Määttä, J | 1 |
| Auriola, S | 1 |
| Coimbra de Sousa, S | 1 |
| Mentrup, B | 1 |
| Graser, S | 1 |
| Rachner, TD | 1 |
| Hofbauer, LC | 1 |
| Jakob, F | 1 |
| Tardoski, S | 1 |
| Ngo, J | 1 |
| Gineyts, E | 1 |
| Roux, JP | 1 |
| Clézardin, P | 1 |
| Melodelima, D | 1 |
2 other studies available for isopentenyl pyrophosphate and Bone Cancer
| Article | Year |
|---|---|
Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Caspase 3; Caspase 7; Cell Line, | 2014 |
Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell | 2015 |